For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide derived from the region aa330 to aa433 of the Human NFkB p50 subunit.
Our Abpromise guarantee covers the use of ab7971 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-Fr||Use at an assay dependent concentration.|
|IP||Use at an assay dependent concentration.|
|WB||1/400. Predicted molecular weight: 50 kDa.Can be blocked with NFkB p105 / p50 peptide (ab8006). PubMed: 16395278|
|ChIP||Use at an assay dependent concentration.|
|Flow Cyt||Use at an assay dependent concentration. Ab171870-Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody.|
|EMSA||Use at an assay dependent concentration. PubMed: 22553204|
|ICC/IF||Use at an assay dependent concentration.|
ICC/IF image of ab7971 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab7971, 5µg/ml) overnight at +4°C. The secondary antibody (green) was a goat anti-rabbit DyLight® 488, pre-adsorbed (ab96899) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
Gating Strategy: Isolate cell population from plot of SSC-A / FSA-A
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"